Analystreport

Catalyst Biosciences Inc (NASDAQ: CBIO) is now covered by analysts at CIBC. They set an "outperform" rating and a $24.00 price target on the stock.

Catalyst Biosciences, Inc.  (CBIO) 
Last catalyst biosciences, inc. earnings: 11/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: catalystbiosciences.com/investors